New Approaches to Improve Coverage and Compliance of Antimalarial Treatment for Pregnant Women in Rural Africa

PHASE3CompletedINTERVENTIONAL
Enrollment

2,766

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

October 31, 2006

Study Completion Date

December 31, 2006

Conditions
Malaria in Pregnancy
Interventions
DRUG

sulfadoxine-pyrimethamine

Sulfadoxine-pyrimethamine given as intermittent therapy, at the dosage of 1500/75 mg per administration (3 tablets), Twice during pregnancy

DRUG

Chloroquine

Chloroquine tablets 100 mg. First administration of 1500 mg given over three days, followed by weekly doses of 300 mg/week

Trial Locations (1)

Unknown

District Sanitaire, Boromo

All Listed Sponsors
collaborator

University of Ouagadougou, Burkina Faso

OTHER

collaborator

National Laboratory of Public Health,Burkina Faso

UNKNOWN

collaborator

Liverpool School of Tropical Medicine

OTHER

collaborator

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

lead

Institute of Tropical Medicine, Belgium

OTHER

NCT00730366 - New Approaches to Improve Coverage and Compliance of Antimalarial Treatment for Pregnant Women in Rural Africa | Biotech Hunter | Biotech Hunter